Whilst these results are notable, direct comparisons with currently approved agents should be interpreted with caution: such comparisons are indirect, based on different trial designs, populations, durations, and background interventions (including lifestyle counselling provided alongside study drug), and cannot be treated as equivalent to head-to-head evidence
Variants in GLP1R, GIPR, FTO, and MC4R determine whether semaglutide's single-pathway approach or tirzepatide's dual mechanism will activate your weight loss biology most effectively, guiding your PlexusDx clinician toward the optimal starting medication
Patients located in Florida who prefer ongoing care often choose the monthly plan for both savings and consistency
Your PlexusDx provider monitors your blood pressure response throughout treatment
Stabilizes blood sugar and prevents energy crashes
What is the difference between Semaglutide and Tirzepatide